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MEF2C is a MADS-box transcription factor required for cardiac myogenesis and morphogenesis. In MEF2C mutant mouse
embryos, heart development arrests at the looping stage (embryonic day 9.0), the future right ventricular chamber fails to
form, and cardiomyocyte differentiation is disrupted. To identify genes regulated by MEF2C in the developing heart, we
performed differential array analysis coupled with subtractive cloning using RNA from heart tubes of wild-type and
MEF2C-null embryos. Here, we describe a novel MEF2C-dependent gene that encodes a cardiac-restricted protein, called
CHAMP (cardiac helicase activated by MEF2 protein), that contains seven conserved motifs characteristic of helicases
nvolved in RNA processing, DNA replication, and transcription. During mouse embryogenesis, CHAMP expression
ommences in the linear heart tube at embryonic day 8.0, shortly after initiation of MEF2C expression in the cardiogenic
egion. Thereafter, CHAMP is expressed specifically in embryonic and postnatal cardiomyocytes. At the trabeculation stage
f heart development, CHAMP expression is highest in the trabecular region in which cardiomyocytes have exited the cell
ycle and is lowest in the proliferative compact zone. These findings suggest that CHAMP acts downstream of MEF2C in


















The heart is the first organ to form during mammalian
embryogenesis (reviewed in Srivastava and Olson, 2000;
Fishman and Chien, 1997). Formation of the heart involves
commitment of cells from the anterior lateral mesoderm to
a cardiogenic fate in response to inductive cues from
adjacent endoderm. Cardiac precursor cells localized to a
region known as the cardiac crescent, which spans the
anterior ventral midline of the embryo, migrate ventrolat-
erally to form a linear heart tube at embryonic day (E) 8.0 in
the mouse. The linear heart tube is patterned from anterior
to posterior into segments that give rise to the outflow
tract, right ventricle, left ventricle, and atria. Rightward
looping of the heart tube is essential for orientation of the
right and left ventricular chambers and alignment of the
heart with the inflow and outflow tracts. Later events of
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All rights of reproduction in any form reserved.hamber maturation, septation, endocardial development,
nd valvulogenesis give rise to the mature multichambered
eart.
Several mouse and zebrafish mutants exhibit specific
efects in cardiac looping, ventricular morphogenesis, and
hamber maturation (reviewed in Fishman and Olson,
997; Stainier, 2000). The phenotypes of these mutants,
hich often result in ablation of specific segments of the
eart, have led to the notion that distinct transcriptional
etworks control formation of different cardiac compart-
ents. Many of the genes shown to be required for these
orphogenetic events encode transcription factors, but the
arget genes that mediate the actions of these factors are
argely unknown.
The basic helix–loop–helix (bHLH) transcription factors,
HAND and eHAND, are expressed preferentially in the
eveloping right and left ventricular chambers, respec-
ively, and have been implicated in formation of these
ardiac segments (Srivastava et al., 1995, 1997; Biben and












































498 Liu et al.required for looping morphogenesis (Lyons, 1995) and is a
regulator of eHAND expression (Biben and Harvey, 1997).
Irx4, a homeodomain protein of a different class, is ex-
pressed specifically in the ventricular chambers and appears
to be both necessary and sufficient for ventricular gene
expression (Bao et al., 1999). The zinc-finger transcription
factors GATA-4 and GATA-5 have also been shown to be
required for ventral morphogenesis and formation of the
linear heart tube in mice and zebrafish, respectively (Kuo et
al., 1997; Molkentin et al., 1997; Reiter et al., 1999).
The MADS-box transcription factor MEF2C is expressed
at the late cardiac crescent stage (E7.75) and subsequently
throughout the linear, looping, and multichambered heart
(Edmondson et al., 1994). At E8.0–8.5 (the linear heart tube
tage), MEF2C mutant and wild-type embryos are indistin-
uishable, whereas by E9.0, when the heart tube should
ndergo rightward looping to form the right ventricular
hamber, the heart tube of MEF2C mutant embryos re-
ains linear, with a single hypoplastic ventricular chamber
used directly to an enlarged atrial chamber (Lin et al.,
997). Cardiomyocytes within the mutant myocardial wall
ecome disorganized at this stage and the heartbeat be-
omes sluggish and irregular. Mutant embryos also develop
ericardial effusion, indicative of hemodynamic insuffi-
iency and heart failure.
There are four MEF2 genes in vertebrates, MEF2A, -B, -C,
nd -D, which are expressed in overlapping patterns in
eveloping muscle and neural cell lineages, and at lower
evels in other cell types (reviewed in Black and Olson,
998). MEF2 factors bind an A/T-rich sequence in the
ontrol regions of numerous skeletal, cardiac, and smooth
uscle-specific genes (Gossett et al., 1989). Functional
edundancy among the vertebrate MEF2 genes has pre-
luded a complete analysis of MEF2 function in the mouse.
owever, in Drosophila, there is only one MEF2 gene,
hich is expressed in developing muscle cell lineages (Lilly
t al., 1994; Nguyen et al., 1994). In Drosophila embryos
acking MEF2, skeletal, cardiac, and visceral myoblasts are
roperly specified and positioned, but they cannot differen-
iate, and there are severe abnormalities in morphogenesis
f the visceral musculature (Lilly et al., 1995; Ranganay-
kulu et al., 1995; Bour et al., 1995). This severe muscle
henotype suggests that MEF2 acts in myoblasts to activate
ownstream muscle-specific genes involved in differentia-
ion and morphogenesis.
To further understand the functions of MEF2C in the
eveloping heart, we attempted to identify MEF2C-
ependent genes by differential array analysis coupled with
ubtractive hybridization using RNA isolated from heart
ubes of wild-type and MEF2C-null mouse embryos. Among
everal MEF2C-dependent genes down-regulated in the
eart tube of MEF2C mutants, we discovered a cardiac-
estricted gene encoding a putative helicase, termed
HAMP (cardiac helicase activated by MEF2 protein), with
omology to RNA helicase superfamily I. Our results
Copyright © 2001 by Academic Press. All rightuggest that CHAMP acts downstream of MEF2C in a
ardiac-specific regulatory pathway for RNA processing
nd/or transcriptional control.
MATERIALS AND METHODS
Breeding of Mice and Genotyping
Mice heterozygous for a MEF2C-null mutation were generated as
previously described (Lin et al., 1997). Intercrosses of MEF2C
heterozygous mice in the mixed 129SVEV/C57BL6 background
were performed to obtain homozygous-null embryos between
E9.0–9.5. Hearts were excised from homozygous embryos and
wild-type littermates and stored frozen at 280°C. Care was taken
to make sure that only viable embryos with beating hearts were
used. Genotypes of individual embryos were determined by PCR
analysis of yolk sac DNA as previously described (Lin et al., 1997).
RNA Preparation, cDNA Synthesis, and
Subtractive Hybridization
Total RNA was prepared by using Trizol reagent (Gibco) from 40
hearts of MEF2C-null and the wild-type littermates, respectively.
Five hundred nanograms each of total RNA were subjected to
reverse-transcription and PCR amplification by using the SMART
cDNA synthesis system (Clontech). Reactions were terminated at
18 cycles in the linear-increase range of PCR amplification. cDNA
larger than 1 kb was enriched by size-fractionation and was
digested with RsaI.
Subtractive hybridization was performed by using wild-type
heart cDNA as a tester and MEF2C-null heart cDNA as a driver
(forward subtraction, WT-KO) by the PCR-Select system (Clon-
tech). Briefly, wild-type heart cDNA was ligated separately with
two different adaptors, and each sample was hybridized with an
excess amount of MEF2C-null heart cDNA. These samples were
combined and hybridized to form double-stranded cDNA with
different adaptors at the ends. cDNA clones representing tran-
scripts specifically expressed in the wild-type heart were preferen-
tially amplified by PCR using the primers specific to the adaptors.
Simultaneously, the reverse subtractive hybridization (KO-WT)
was also performed using MEF2C-null heart cDNA as a tester and
wild-type heart cDNA as a driver to enrich for cDNA representing
transcripts highly expressed in MEF2C-null hearts.
Differential Array Analysis
Subtracted PCR fragments were subcloned into pCRII-TOPO
plasmids (Invitrogen), and 1000 bacterial clones were recovered and
cultured for 5 h. cDNA inserts of the plasmid clones were amplified
by PCR using adapter-specific primers and were arrayed in dupli-
cate onto replica nylon membranes. Subtracted PCR fragments
from the forward (WT-KO) and reverse (KO-WT) subtractions were
labeled with [32P]dCTP. Each membrane was hybridized with either
forward or reverse probes in Rapid-hyb buffer (Amersham) at 65°C
and washed serially, with a final wash in 0.13 SSC, 0.1% SDS at
65°C. Autoradiography was performed by using PhosphorImaging
(Molecular Dynamics). After stripping and prehybridization, one of
the replica membranes was hybridized with 32P-labeled cDNA
probes prepared from whole embryo without heart tissues.
































499CHAMP, a MEF2C-Dependent Cardiac HelicaseSouthern Blot Analysis of PCR-Amplified cDNA
To examine the expression patterns of isolated genes in MEF2C-
ull hearts and wild-type hearts, we performed Southern blot
nalysis of PCR fragments obtained by SMART cDNA synthesis
“virtual” Northern analysis). Approximately the same amount of
DNA mixtures for the MEF2C-null hearts, wild-type hearts, and
hole embryo minus heart tissues was electrophoresed on a 1.5%
garose/TAE gel and transferred onto nylon membranes. The
embranes were hybridized with the PCR fragments of individual
lones in Rapid-hyb buffer at 65°C and washed serially, with a final
ash in 0.13 SSC, 0.1% SDS at 65°C. Signals were visualized by
utoradiography.
Isolation and Characterization of CHAMP
The original 0.6-kb cDNA clone R15-C5 isolated from subtrac-
tive cloning was used to screen a mouse E10.5 heart cDNA library
(Stratagene) and an adult heart cDNA library (Clontech). The
longest cDNA obtained from these libraries was 1.6 kb in length.
The remaining 0.4 kb of sequence at the 59 end was obtained by
59-RACE, using gene-specific primers from the 59 end of the 1.6-kb
clone. The final 2.0-kb cDNA clone contained no 59-UTR. Exten-
sive efforts have failed to identify additional 59 sequence for the
HAMP cDNA. The sequence of the 2-kb cDNA has been depos-
ted in GenBank with accession number AF340211.
Bioinformatics
Using BLAST search with CHAMP, significant homologies were
obtained with the helicase Mov-10 (Mooslehner et al., 1991), Upf1p
(Leeds et al., 1991), Smubp-2 (Chen et al., 1997), and Hcs1p (Biswas
et al., 1997) (E value , e225). All of these helicases are from the
helicase superfamily I (de la Cruz et al., 1999). The sequence
alignments of CHAMP with Mov-10, Upf1p, Smubp-2, and Hcs1p
were performed with ClustalW alignment and manually adjusted.
An EST (accession no. AL133068) that appears to encode por-
tions of the testis isoform of human CHAMP was obtained by using
tblastn with CHAMP. The open reading frame of the EST
AL133068 (678 amino acids) was further used in a BLAST search,
and a larger protein sequence (1315 amino acids) conceptually
translated from human chromosome 22q13 was obtained (acces-
sion no. 10880095). The C-terminal portion of this sequence
overlaps with the open reading frame of EST AL133068 and has 690
more residues at its N terminus. A putative testis isoform of
human CHAMP was deduced by using sequences of EST
AL1033068 and 10880095. The genomic structure of CHAMP was
obtained by BLASTing the human genome database with the
sequence of putative human testis CHAMP.
In Situ Hybridization
Whole-mount in situ hybridization and radioactive section in
itu hybridization were performed as previously described (Naka-
awa et al., 1999) on mouse embryos from E7.75 to E15.5 and on
dult mouse heart. Plasmids containing nucleotides 589–994 and
420–2020 of the CHAMP cDNA (See Fig. 3) were used as the
emplates for making 35S-UTP-labeled and digoxigenin-labeled ri-
oprobes for section and whole-mount in situ hybridization, re-
spectively. cDNA probes corresponding to these two fragments
yielded the same results on Northern blot analysis (see below). B
Copyright © 2001 by Academic Press. All rightNorthern Blot Analysis
Northern blot analysis was performed on a mouse adult tissue
poly(A)1 RNA blot (Clontech) by using 32P-labeled CHAMP cDNA
ragments corresponding to nucleotides 589–994 and 1420–2020 as
robes. The membrane was prehybridized and hybridized in Rapid-
yb buffer at 65°C and washed serially, with a final wash in 0.23
SC, 0.1% SDS at 65°C. Autoradiography was performed at 280°C
or 15 h with an intensifying screen.
Preparation of Anti-CHAMP Antibody and
Immunostaining
Rabbit polyclonal anti-CHAMP antibody was raised against
residues 531–550 near the carboxyl terminus. The antibody was
affinity-purified with peptide antigen using a Sufolink kit (Pierce).
For immunoblot analysis of CHAMP protein, cell extracts were
separated by SDS–PAGE, transferred to PVDF membranes, and
probed with affinity-purified anti-CHAMP antibody at 1/1000
dilution. Antibody–antigen complexes were visualized by a chemi-
luminescence detection system (Tropix). Indirect immunofloures-
cence staining of N-terminal FLAG-tagged CHAMP in HeLa cells
was performed following a protocol with anti-CHAMP antibody at
1/50 dilution and monoclonal anti-FLAG antibody M2 (McKinsey
et al., 2000). Immunohistochemistry was performed by using
anti-CHAMP antibody on paraffin-embedded tissue sections, as
described (Cianga et al., 1999).
RESULTS
Identification of MEF2C-Dependent Genes
To identify potential MEF2C-dependent genes in the
early heart tube, we performed differential array analysis
using cDNA derived from subtractive hybridization of RNA
isolated from heart tubes of wild-type and MEF2C mutant
embryos at E9.0 to E9.5. At this stage, homozygous mutants
were viable and were visually identifiable by cardiac mal-
formation. The genotypes of individual embryos were con-
firmed by PCR analysis of yolk sac DNA.
One thousand cDNA clones obtained from subtractive
hybridization of wild-type and MEF2C-null heart tubes
were arrayed in duplicate onto replica nylon membranes.
The arrayed membranes were then probed with cDNA from
the forward and reverse subtractions as described in Mate-
rials and Methods. To identify clones that were potentially
cardiac-specific, one of the arrays was subsequently
stripped and hybridized with 32P-labeled cDNA prepared
rom wild-type embryos without the heart.
Approximately 169 of 1000 arrayed clones, obtained from
he initial subtraction, showed higher expression in wild-
ype compared to MEF2C mutant heart tubes. Of these 169
otential MEF2-dependent clones, 54 appeared to be
ardiac-specific, based on their lack of hybridization to
DNA from embryos without the heart. The clones that
howed more than 3-fold differences in expression between
ild-type and mutant heart tubes are listed in Table 1.
ased on sequence analysis, we were able to categorize









500 Liu et al.MEF2C-dependent genes into four major classes: (1) muscle
genes, (2) stress- and growth-related genes, (3) genes encod-
ing enzymes involved in electron transport and ATP syn-
thesis, and (4) novel genes. The expression patterns of
representative genes from each class were confirmed by
“virtual” Northern analysis, in which RNA from wild-type
and MEF2C mutant heart tubes, and from E9.25 embryos
ithout the heart, was converted to cDNA and probed by
outhern blot (data not shown).
As expected, muscle-specific genes represented a signifi-
ant proportion of the MEF2C-dependent genes (Table 1).
ultiple contractile protein genes and genes encoding pro-
eins involved in calcium handling [calsequestrin, sarco-
lasmic reticulum Ca21-ATPase (SERCA) and Na1/Ca21
exchanger (NCX1)] were specifically down-regulated in mu-
tant hearts. Among muscle genes found to be dependent on
MEF2C, cardiac troponin T, myosin light chain (MLC)-2,
and MLC-3 have been shown to contain essential MEF2
sites in their promoters (Ross et al., 1996; McGrew et al.,
1996; Lin et al., 1997), suggesting that they are direct targets
for MEF2C.
Several genes encoding proteins involved in protein deg-
radation (ubiquitin protein ligase Nedd-4) and protein fold-
TABLE 1
Classification of MEF2C-Dependent cDNA Clones
Genes Numbers of clones
Muscle genes
Myosin light chain-2 2
Myosin light chain-3 3
Titin 3
Vascular smooth muscle a-actin 1




Muscle LIM protein 2
Slow skeletal muscle troponin I 1
tress-response and growth-related genes
aB-crystallin 2
Cripto 3
Pituitary tumor transforming gene (PTTG) 1
Hsp60 2
Proteasome subunit RC10-11 1
Ubiquitin protein ligase Nedd-4 1
Electron transport and energy production genes
ATPase subunit 6 10
NADH dehydrogenase subunit 1 2
Cytochrome oxidase subunit 1 (COX1) 3
Cytochrome oxidase subunit 2 (COX2) 1
ATP synthase a subunit 1
ATP synthase g subunit 1
Novel genes 10ing (Hsp60 and aB-crystallin) were also identified from the
Copyright © 2001 by Academic Press. All rightubtraction screen (Table 1). Among these, aB-crystallin is
expressed in the primitive heart tube at E8.5 and subse-
quently throughout the developing heart, as well as skeletal
muscle lineages (Benjamin et al., 1997), in a pattern that
overlaps that of MEF2C during embryogenesis (Edmondson
et al., 1994).
We also identified two genes that are cell growth-related,
pituitary tumor transforming gene (PTTG) and Cripto.
PTTG has been demonstrated to be capable of inducing
fibroblast growth factor expression in vitro. Its expression
strongly correlates with pituitary tumorigenesis (McCabe
and Gittoes, 1999). The promoter region of rat PTTG
contains two MEF2C consensus binding sites at 2909 to
2900 (CTAAAAATAA) and at 2780 to 2771 (CTTTAAT-
TAA) (Pei, 1998), suggesting that it may be a direct target of
MEF2C. Cripto, a member of the EGF-CFC protein family
(Shen and Schier, 2000), is expressed in the forming heart at
E7.5–8.0, concomitant with MEF2C expression, and is
required for cardiac development (Dono et al., 1993; John-
son et al., 1994; Minchiotti et al., 2000).
The largest class of genes down-regulated in MEF2C
mutants encoded proteins involved in energy metabolism
and electron transport (Table 1). Since several of these genes
are encoded by the mitochondrial genome, we believe that
their down-regulation may be a secondary pathophysiologi-
cal consequence of heart failure in mutant embryos.
We also identified numerous novel clones representing
MEF2C-dependent genes. Some of these sequences had no
matches in EST databases, whereas others matched ESTs
with no known functions. Since the cDNAs isolated by this
technique are biased toward 39-untranslated regions, it is
possible that some of these sequences represent unidenti-
fied 39 portions of known genes. Confirmation of the
uniqueness of these clones will require isolation of full-
length cDNAs (see below).
CHAMP, A Cardiac Helicase Regulated by MEF2C
We chose to focus on one of the novel MEF2C-dependent
cDNAs, clone R15-C5, which was found by virtual North-
ern blot to represent a cardiac-restricted transcript ex-
pressed at levels about 5-fold higher in heart tubes from
wild-type embryos compared with MEF2C mutants (Fig.
1A). This differential expression pattern was confirmed by
whole-mount in situ hybridization with E8.0 embryos (Fig.
1B). R15-C5 transcripts were expressed throughout the
heart tube of wild-type embryos, whereas they were unde-
tectable in MEF2C mutants at this stage.
The initial R15-C5 cDNA was 600 nucleotides in length
and contained only a short open reading frame followed by
a noncoding region and a poly(A) stretch, suggesting that it
represented the 39 end of a transcript. At the time it was
first identified, there was no match for this sequence in the
database, but subsequently, we found ESTs from mouse
testis, ovary, and heart. Screening of mouse E10.5 embryo
and adult heart cDNA libraries and 59-RACE (see Materials






































501CHAMP, a MEF2C-Dependent Cardiac Helicaseand Methods) yielded a cDNA clone of about 2 kb. Using
cDNA fragments derived from this clone as probes in
Northern blots of adult mouse tissues, we detected a single
2-kb transcript only in the heart and lower levels of a 4.4-kb
transcript in testis (Fig. 2).
Sequencing of the 2-kb cDNA clone revealed an ATG
codon at the beginning of a 550-amino acid open reading
frame with the potential to encode a putative protein with
a predicted molecular weight of 62 kDa, pI 9.2 (Fig. 3). This
novel protein contains seven conserved motifs characteris-
tic of RNA helicase superfamily I (de la Cruz et al., 1999).
ased on its cardiac-specific expression and homology to
ther helicases, we refer to this protein as cardiac helicase
ctivated by MEF2 protein, CHAMP. CHAMP is most
losely related to Mov-10 (Fig. 3C), a protein of unknown
unction first identified from a random proviral integration
n a transgenic mouse strain (Mooslehner et al., 1991). In
ontrast to CHAMP, Mov-10 is expressed ubiquituously.
ther related helicases include Upf1, which mediates the
egradation of nonsense mRNAs (Leeds et al., 1991; Cui et
l., 1995), smupb2, which acts as a transcriptional activator
r repressor (Chen et al., 1997; Fukita et al., 1993; Shieh et
al., 1995), and Hcs1p, a DNA helicase required for DNA
replication (Biswas et al., 1997) (Fig. 3C).
Members of RNA helicase superfamily I are related
FIG. 1. RC15–5 expression in wild-type and MEF2C mutant emb
analysis by using cDNA prepared from heart tubes of wild-type
without heart, as described in Materials and Methods. a-Enolase
included as a control. (B) Transcripts for R15-C5 were detected b
utant embryos. R15-C5 transcripts were specifically expressed in
utant. h, heart; hf, headfold.through a common central region, containing the seven t
Copyright © 2001 by Academic Press. All rightonserved motifs flanked by divergent sequences at both
nds (Fig. 3D). This central region is essential and sufficient
or helicase activity, which unwinds RNA and/or DNA
uplexes with energy derived from ATP hydrolysis (de la
ruz, 1999). Mutational analyses have revealed that motifs
, Ia, and II are involved in ATP binding and hydrolysis
Weng et al., 1996). Motifs III and VI are involved in
nwinding activity and RNA/DNA binding, respectively.
he variable N- and C-terminal regions of superfamily I
elicases have been postulated to participate in recognition
nd subcellular localization of substrates. The sequences of
he seven helicase motifs, as well as their spacing, in
HAMP were highly conserved relative to other members
f this helicase superfamily. CHAMP also contains five
epeated motifs of the sequence TRNDXQSITNV/I near the
mino terminus (Fig. 3B). These motifs do not correspond to
he consensus for any protein kinases nor are they found in
ny other proteins we have been able to identify.
We also characterized the CHAMP transcript expressed
n testis by isolating corresponding cDNAs and by analysis
f genomic sequence conceptually translated from human
hromosome 22q13 by the NCBI annotation project (acces-
ion no. 10880095). Based on this information, we found
hat the open reading frame of the human testis transcript
ncodes at least 826 additional amino acids at the 59 end of
. (A) Transcripts for R15-C5 were detected by “virtual” Northern
EF2C mutant embryos at E9.0–E9.5 and whole E9.25 embryos
ch is expressed ubiquitously and is independent of MEF2C, was
ole-mount in situ hybridization with E8.0 wild-type and MEF2C




the hhe cardiac sequence (data not shown; sequence is available











502 Liu et al.upon request.). Comparison of cDNA and genomic se-
quence indicates that the cardiac transcript of human
CHAMP is encoded by 13 exons (data not shown). The
extended sequence predicted for the testis form of CHAMP
is contained in 15 additional exons. Thus, the entire human
gene is predicted to contain 28 exons, spanning 73 kb of
DNA. These findings suggest that the cardiac and testis
isoforms are generated from different promoters.
Embryonic Expression Pattern of CHAMP
The expression pattern of CHAMP during mouse em-
bryogenesis was determined by in situ hybridization.
CHAMP transcripts were not detected in the cardiac cres-
cent at E7.75 by whole-mount in situ hybridization (data
not shown). CHAMP expression was first observed in the
linear heart tube at E8.0 (Fig. 4A). The highest expression of
CHAMP was in the anterior region of the primitive heart
tube that is fated to form the ventricular segments.
CHAMP expression was not detected at the most posterior
branches of the forming heart tube at this stage (Fig. 4A).
These branches, known as the sinus venosae, later form the
atrial chambers (DeHaan, 1965). The onset of CHAMP
expression is about a half-day later than the initial expres-
sion of MEF2C (Edmondson et al., 1994), which is consis-
tent with CHAMP being a downstream target gene of
EF2C. The ventricular expression of CHAMP was main-
ained in the looped heart tube at E9.5 (Fig. 4B). At this
tage, a low level of CHAMP expression was also detectable
FIG. 2. Northern analysis of CHAMP RNA expression. CHAMP
transcripts were detected by Northern analysis of RNA from the
indicated adult mouse tissues. A single transcript of about 2 kb was
detected in the adult heart and a larger and less abundant transcript
of about 4.4 kb was detected in testis. Equivalent quantities of
RNA were loaded in each lane.n atrial precursor cells. Subsequently, CHAMP expression
Copyright © 2001 by Academic Press. All rightas seen exclusively in the heart throughout development
nd into adulthood (Figs. 4D–4G). Radioactive section in
itu hybridization at E13.5 and E15.5 indicated that
HAMP was specifically expressed within myocardial cells
Fig. 4D). No CHAMP expression was detected in the
mbryonic vasculature or outflow tract.
FIG. 3. Deduced amino acid sequence of CHAMP and its align-
ment to other helicases. (A) Schematic diagram of the CHAMP
protein. The positions of the seven conserved motifs characteristic
of RNA/DNA helicases are indicated. (B) The mouse CHAMP
cDNA contained an open reading frame of 550 amino acids, a
370-bp 39-UTR, and a putative polyadenylation signal not shown.
The seven conserved helicase motifs are underlined. The
TRNDXQSITNV/I repeats near the amino-terminus are designated
by double underlines. (C) Sequence alignment of CHAMP with
members of RNA helicase superfamily I: mouse Mov-10 (Genpept
accession no. 127560), human UPF1 (GI 1633577), yeast Upf1p (GI
83347), mouse Smubp-2 (GI 730752), and yeast Hcs1p (GI 6322835).
(D) The seven conserved helicase motifs of CHAMP are shown
aligned with similar motifs in the aforementioned RNA helicase
superfamily members. The number of amino acids that flank the
helicase motifs are shown in parentheses. The conserved func-
tional motifs include an ATPase motif (I, Ia and II), helicase motif
(III), and RNA binding motif (VI).
s of reproduction in any form reserved.
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504 Liu et al.Subcellular Localization of CHAMP
Using an antibody raised against residues 531–550 of
CHAMP, we examined the size and subcellular distribution
of the protein. Western blot analysis showed that FLAG-
tagged CHAMP from transfected HeLa cells migrated as a
single band of 62 kDa (Fig. 5A, lanes 2 and 4) that comi-
grated with the endogenous protein from adult mouse heart
extracts (Fig. 5A, lane 5). The bands from transfected HeLa
cells and heart extracts were effectively competed when the
antibody was preadsorbed with the CHAMP antigen used to
generate the antibody (Fig. 5A, lanes 7 and 8). We conclude
from these results that the cloned cDNA encodes the form
of CHAMP protein expressed in the heart. The anti-
CHAMP antibody also detected a band of about 170 kDa in
heart extracts that was competed by the cognate peptide.
We are uncertain of the identity of this protein, but it seems
unlikely to be a larger form of CHAMP because the 2-kb
CHAMP transcript detected in heart is not large enough to
encode a protein of this size.
The subcellular localization of the CHAMP protein was
examined by immunofluorescent staining of HeLa cells
transfected with an expression vector encoding FLAG-
tagged CHAMP (Fig. 5B). CHAMP was localized predomi-
nantly to the cytoplasm of transfected HeLa cells. Immu-
nofluorescent staining of sections of embryonic mouse
hearts with anti-CHAMP antibody also showed that endog-
enous CHAMP protein was localized primarily to the
cytoplasm of cardiomyocytes. At E10.5, CHAMP expres-
sion was restricted specifically to cardiac myocytes, with
no detectable staining in epicardial or endocardial cells
(Figs. 6A and 6B). By E15.5, when the ventricular wall
consists of a well-defined proliferating compact zone and
less mitotically active trabeculations, expression of
CHAMP appeared to be graded, with highest levels in
myocytes within the trabeculations (Fig. 6E) and lowest
levels in the proliferating compact zone (Fig. 6D).
DISCUSSION
Through an analysis of cDNA clones representing
MEF2C-dependent genes in the mouse heart tube, we
identified a novel cardiac-restricted helicase, CHAMP, in
addition to numerous muscle-specific and more widely
expressed genes that appear to require MEF2C for expres-
sion. CHAMP expression is restricted to embryonic and
postnatal cardiomyocytes, although an alternative tran-
script is expressed at a low level in testis. Consistent with
the conclusion that CHAMP expression is dependent on
MEF2C, CHAMP transcripts are not detected until E8.0,
the linear heart tube stage, a half-day after MEF2C is first
expressed in the cardiac crescent (Edmondson et al., 1994).
HAMP appears to be expressed in an anterior–posterior
radient along the heart tube at E8.0, an expression pattern
imilar to that of a lacZ reporter gene controlled by tandem
opies of the MEF2 consensus sequence (Naya et al., 1999)
Copyright © 2001 by Academic Press. All rightnd transgenes controlled by the MLC-2v and desmin
romoters, which require MEF2 binding sites for expression
Ross et al., 1996; Kuisk et al., 1996).
The expression of CHAMP at the time of cardiac looping
nd trabeculation is similar to that of neurotrophin-3
NT-3) and its receptor Trk C (Lin et al., 2000). The
T-3:trk C signaling pathway regulates cardiac myocyte
roliferation at this stage of heart development (Lin et al.,
000). Whether the preferential expression of CHAMP in
he trabecular region of the developing heart, where the
roliferative rate is diminished, reflects a role for CHAMP
s a negative regulator of cardiomyocyte proliferation and
rowth remains to be determined.
Functions of RNA Helicase Superfamily I
CHAMP is most closely related to members of RNA
helicase superfamily I, which includes yeast Upf1p, Sen1p,
Hcs1p, and murine Smubp-2. Members of this helicase
superfamily play diverse roles in DNA and RNA metabo-
lism (de la Cruz et al., 1999). Upf1p is required for nonsense
mRNA decay to limit the accumulation of aberrant pro-
teins that arise through inefficient splicing and premature
termination of translation (Leeds et al., 1991; Cui et al.,
1995). Upf proteins are also required to control the accu-
mulation of a large number of mRNAs (Lelivelt et al., 1999).
Yeast Upf1p has been shown to possess helicase activities
that unwind both RNA and DNA duplexes unidirectionally
from 59 to 39 ends (Czaplinski, 1995; Kim et al., 1999).
Sen1p is required for tRNA splicing and has been postulated
to be involved in biosynthesis and processing of other
RNAs, such as rRNA and small nuclear and nucleolar
RNAs (DeMarini et al., 1992; Kim et al., 1999). Hcs1p is a
DNA helicase required for DNA replication (Biswas et al.,
1997), and Smubp-2 is a transcription factor (Chen et al.,
1997; Sebastiani et al., 1995). Smubp-2 has been shown to
bind two 12-o-tetracanoylphorbol-13-acetate-responsive el-
ements in the Epstein–Barr virus immediate-early BZLF1
promoter (Gulley et al., 1997), which is regulated by MEF2
(Liu et al., 1997). Overexpression of Smubp-2 in B lympho-
cytes represses the BZLF1 gene promoter, possibly by
disruption of a functional TBP-TFIIA-TATA box complex
(Zhang et al., 1999). The Rat homolog of Smubp-2 (cardiac
transcription factor-1) was proposed to transactivate the
atrial natriuretic factor (ANF) promoter through interac-
tion with a cis-acting myocyte-specific element (Sebastiani
et al., 1995). RNA helicases have also been implicated in
transcriptional coregulation during development (Naka-
jima, et al., 1997). We have tested the potential responsive-
ness of several cardiac gene promoters, including the ANF
promoter, to CHAMP, but have observed no effect (data not
shown).
CHAMP protein appears to be localized primarily to the
cytoplasm of cardiomyocytes, suggesting that its biochemi-
cal substrate may be RNA in nature. Human Upf1 and Upf2
are also cytoplasmic proteins and function in translational


































505CHAMP, a MEF2C-Dependent Cardiac Helicasetermination and in monitoring translational fidelity (Serin
et al., 2001). Other cytoplasmic RNA helicases include
eiF-4A and the Drosophila protein VASA. eiF-4A is thought
o function in unwinding mRNA during translational ini-
FIG. 4. CHAMP expression during mouse embryogenesis de-
tected by whole-mount and radioactive section in situ hybridiza-
ion. CHAMP expression was detected by whole-mount in situ
ybridization with mouse embryos at E8.0 (A) and E9.5 (B). (C) A
ransverse vibratome section of the embryo shown in (B). (D–G)
adioactive in situ hybridizations of CHAMP transcripts. (D, E)
agittal sections of E10.5 and 13.5 embryos, respectively. (F) A
agittal section of the heart of an E15.5 embryo. (G) A transverse
ection of the heart of an E15.5 embryo. CHAMP transcripts were
etected only in myocardial cells. Staining in the head in (B) is
onspecific background. a, atrium; h, heart; la, left atrium; lr, left
entricle; ra, right atrium; rv, right ventricle; sv, sinus venosae; v,
entricle.iation (Rozen et al., 1990). VASA is required for the a
Copyright © 2001 by Academic Press. All rightormation of posterior pole plasm (Lasko and Ashburner,
998). VASA acts as positive regulator of oskar RNA
translation (Webster et al., 1997) and is required for the
proper localization and translation of nanos RNA (Gavis et
al., 1996). It is possible that CHAMP may control the
proliferation of cardiomyocytes by regulating the mRNAs
of proteins involved in cell cycle progression. Interestingly,
a new RNA helicase, carpel factory (CAF), has been identi-
fied in Arabidopsis thaliana (Jacobson et al., 2000). CAF
cts epistatically downstream of a MADS-box type tran-
cription factor Agamous. Disruption of CAF causes un-
egulated cell division.
Other MEF2C-Dependent Genes
In addition to CHAMP, we identified numerous muscle
structural genes, as well as genes encoding growth and
stress-responsive proteins, that appear to be regulated by
MEF2C. Several of the muscle genes identified have been
shown to be direct targets for MEF2. Whether the others
also contain MEF2-binding sites in their control regions, or
whether they are regulated indirectly by MEF2, remains to
be determined. It should be pointed out that there are
cardiac genes, such as ANF, cardiac a-actin, a-myosin
heavy chain, and MLC-1A, that were shown previously to
be down-regulated in the hearts of MEF2C mutants (Lin et
al., 1997), but were not identified in our screen. Thus, the
screen was not completely saturating, despite the fact that
several differentially expressed genes were identified mul-
tiple times.
Unexpectedly, the largest number of MEF2C-dependent
sequences identified in our screen encoded proteins in-
volved in energy metabolism and electron transport. Some
of these genes, such as those encoding ATPase subunit 6
and ATP synthase a and g subunits, are nuclear, whereas
thers are encoded by the mitochondrial genome. A similar
ubtractive scheme to identify genes dependent on the
etinoic acid X receptor (RXR)-a in the heart at mid (E10.5)
and late (E13.5) stages identified five metabolic genes,
including the gene encoding the 14.5-kb subunit of the
NADH-ubiquinone oxidoreductase complex, as being
RXRa-dependent (Ruiz-Lozano et al., 1998). It is interesting
o note that nuclear-encoded muscle-specific forms of some
ytochrome c oxidase genes contain a number of striated
uscle-specific regulatory motifs, including MEF2 sites in
heir proximal promoter regions (see review by Lenka et al.,
998).
Cardiac contractions are first observed as a peristaltic
ave at E8.0 in the mouse, and contractions become
tronger and more rhythmic as the heart undergoes looping
nd the chambers develop at E9.5. At this stage, the heart
epends on oxidative phosphorylation to meet its high
nergy demands. The down-regulation of the above genes
ould be expected to result in depletion of cellular ATP
tores with resulting energy deprivation and heart failure,
s is observed in MEF2C mutant embryos.
s of reproduction in any form reserved.
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In addition to the essential role of MEF2C in cardiac
development, recent studies have revealed a potential role
for MEF2 factors in cardiac hypertrophy in response to
pressure overload and other stimuli (Passier et al., 2000;
Kolodziejczyk et al., 1999; reviewed in Naya and Olson,
1999). Signal-dependent activation of MEF2-dependent
genes has been shown to involve mitogen-activated protein
kinase (Zhao et al., 1999), calcium, calmodulin-dependent
FIG. 5. Detection of CHAMP protein by immunoblot and immu-
nofluorescence. (A) HeLa cells were transfected with pcDNA-
FLAG-CHAMP (1) or pcDNA vector alone (2) as a negative control
(lanes 1–4). Twenty-four hours later, cell extracts were prepared
and CHAMP protein was detected by Western blot with anti-FLAG
(lanes 1 and 2) or anti-CHAMP (lanes 3 and 4) antibody. In lanes
6–8, anti-CHAMP antibody was preadsorbed with peptide antigen
prior to performing the Western blot. Cell extracts from adult
mouse heart were immunoblotted with anti-CHAMP antibody in
lanes 5 and 8. (B) HeLa cells transfected with pcDNA-FLAG-
CHAMP were stained with anti-FLAG antibody (left) and with
anti-CHAMP antibody (right), using Texas-Red conjugated with
anti-mouse IgG and FITC conjugated with anti-rabbit IgG as the
secondary antibody, respectively.protein kinase (Passier et al., 2000; Lu et al., 2000), and
Copyright © 2001 by Academic Press. All rightcalcineurin (Chin et al., 1998; Mao et al., 1999; Wu et al.,
2000), as well as the Notch signaling pathway (Wilson-
Rawls et al., 1999). In this regard, it is notable that many of
the genes that were found to be down-regulated in MEF2C-
null heart tubes are up-regulated during cardiac hypertro-
phy (Hwang et al., 1997). Thus, it will be especially inter-
esting to determine whether MEF2 factors regulate the
same sets of genes in the adult myocardium as in the early
heart tube and whether genes that are regulated by MEF2 in
the embryonic heart are involved in reactivation of the
“fetal” gene program during hypertrophic growth of the
adult myocardium. It will also be interesting to determine
FIG. 6. Immunostaining of CHAMP in the heart of an E10.5
mouse embryo. Paraffin-embedded sagittal sections of a mouse
E10.5 (A and B) and E15.5 (C–E) embryos were deparaffinized and
probed with anti-CHAMP antibody. The bound anti-CHAMP an-
tibody was detected by sequential incubation with biotinylated
secondary antibody, followed by horseradish peroxidase-conjugated
streptavidin, and visualized after addition of diaminobenzidine.
Sections were counterstained with hematoxylin. CHAMP protein
was restricted to myocardial cells (m) and was not detected in
endocardial (e) or epicardial cells. a, atrium; v, ventricle. At E15.5,
CHAMP staining was highest in the trabecular region (E) and was
much reduced in the proliferative compact zone (D).
s of reproduction in any form reserved.
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